Literature DB >> 33564701

Body Composition Influences Post-Operative Complications and 90-Day and Overall Survival in Pancreatic Surgery Patients.

Sónia Velho1, Maria Pia Costa Santos2, Cátia Cunha3, Lisa Agostinho4, Rita Cruz4, Filipe Costa5, Mafalda Garcia3, Paulo Oliveira3, Rui Maio3,5, Vickie E Baracos6, Marília Cravo2,5,7.   

Abstract

INTRODUCTION: Pancreatic surgery still carries a high morbidity and mortality even in specialized centers. The aim of this study was to evaluate the influence of patients' body composition on postoperative complications and survival after pancreatic surgery.
METHODS: This was a retrospective study on patients undergoing pancreatic surgery between March 2012 and December 2017. Demographics, clinical data, and postoperative complications classified according to Clavien-Dindo were recorded. Body composition was assessed using routine diagnostic or staging computed tomography (CT). Multiple Cox proportional hazards models were adjusted.
RESULTS: Ninety patients were included, 55% were male, and the mean age was 68 ± 10.9 years. Of these 90, 92% had a total pancreatectomy or pancreaticoduodenectomy, 7% a distal pancreatectomy, and 1% a pancreaticoduodenectomy with multi-visceral resection; 84% had malignant disease. The incidence of major complications was 27.8% and the 90-day mortality was 8.8%. The ratio of visceral fat area/skeletal muscle area (VFA:SMA) was associated with an increased risk of complications (OR 2.24, 95% CI 1.14-4.87, p = 0.03) and 90-day survival (HR 2.13, 95% CI 1.13-4.01, p = 0.019). On simple analysis, shorter overall survival (OS) was observed in patients aged ≥70 years (p = 0.0009), with postoperative complications ≥IIIb (p = 0.01), an increased VFA:SMA (p = 0.007), and decreased muscle radiation attenuation (p = 1.6 × 10-5). In an OS model adjusted for age, disease malignancy, postoperative complications, and body composition parameters, muscle radiation attenuation remained significantly associated with survival (HR 0.94, 95% CI 0.90-0.98, p = 0.0016). A model which included only body composition variables had a discrimination ability (C-statistic 0.76) superior to a model which comprised conventional clinical variables (C-statistic 0.68).
CONCLUSION: Body composition is a major determinant of postoperative complications and survival in pancreatic surgery patients.
Copyright © 2020 by Sociedade Portuguesa de Gastrenterologia. Published by S. Karger AG, Basel.

Entities:  

Keywords:  Body composition; Muscle attenuation; Pancreatic surgery; Postoperative complications; Ratio of visceral fat area/skeletal muscle area; Survival

Year:  2020        PMID: 33564701      PMCID: PMC7841797          DOI: 10.1159/000507206

Source DB:  PubMed          Journal:  GE Port J Gastroenterol        ISSN: 2387-1954


  31 in total

Review 1.  Borderline resectable pancreatic cancer. Challenges and controversies.

Authors:  Luis Sabater; Elena Muñoz; Susana Roselló; Dimitri Dorcaratto; Marina Garcés-Albir; Marisol Huerta; Desamparados Roda; María Carmen Gómez-Mateo; Antonio Ferrández-Izquierdo; Antonio Darder; Andrés Cervantes
Journal:  Cancer Treat Rev       Date:  2018-06-13       Impact factor: 12.111

2.  Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer.

Authors:  Shinya Okumura; Toshimi Kaido; Yuhei Hamaguchi; Yasuhiro Fujimoto; Toshihiko Masui; Masaki Mizumoto; Ahmed Hammad; Akira Mori; Kyoichi Takaori; Shinji Uemoto
Journal:  Surgery       Date:  2015-03-19       Impact factor: 3.982

3.  Impact Total Psoas Volume on Short- and Long-Term Outcomes in Patients Undergoing Curative Resection for Pancreatic Adenocarcinoma: a New Tool to Assess Sarcopenia.

Authors:  Neda Amini; Gaya Spolverato; Rohan Gupta; Georgios A Margonis; Yuhree Kim; Doris Wagner; Neda Rezaee; Matthew J Weiss; Christopher L Wolfgang; Martin M Makary; Ihab R Kamel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2015-04-30       Impact factor: 3.452

4.  Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort study.

Authors:  Go Ninomiya; Tsutomu Fujii; Suguru Yamada; Norimitsu Yabusaki; Kojiro Suzuki; Naoki Iwata; Mitsuro Kanda; Masamichi Hayashi; Chie Tanaka; Goro Nakayama; Hiroyuki Sugimoto; Masahiko Koike; Michitaka Fujiwara; Yasuhiro Kodera
Journal:  Int J Surg       Date:  2017-01-18       Impact factor: 6.071

5.  Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index.

Authors:  Lisa Martin; Laura Birdsell; Neil Macdonald; Tony Reiman; M Thomas Clandinin; Linda J McCargar; Rachel Murphy; Sunita Ghosh; Michael B Sawyer; Vickie E Baracos
Journal:  J Clin Oncol       Date:  2013-03-25       Impact factor: 44.544

6.  Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer.

Authors:  Benjamin H L Tan; Laura A Birdsell; Lisa Martin; Vickie E Baracos; Kenneth C H Fearon
Journal:  Clin Cancer Res       Date:  2009-11-03       Impact factor: 12.531

7.  Impact of sarcopenia in borderline resectable and locally advanced pancreatic cancer patients receiving stereotactic body radiation therapy.

Authors:  William H Jin; Eric A Mellon; Jessica M Frakes; Gilbert Z Murimwa; Pamela J Hodul; Jose M Pimiento; Mokenge P Malafa; Sarah E Hoffe
Journal:  J Gastrointest Oncol       Date:  2018-02

8.  Imaging body composition in cancer patients: visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcome.

Authors:  Connie Yip; Charlotte Dinkel; Abhishek Mahajan; Musib Siddique; Gary J R Cook; Vicky Goh
Journal:  Insights Imaging       Date:  2015-06-13

9.  Computed tomography diagnosed cachexia and sarcopenia in 725 oncology patients: is nutritional screening capturing hidden malnutrition?

Authors:  Éadaoin B Ní Bhuachalla; Louise E Daly; Derek G Power; Samantha J Cushen; Peter MacEneaney; Aoife M Ryan
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-12-21       Impact factor: 12.910

10.  Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.

Authors:  Daniel Dindo; Nicolas Demartines; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

View more
  1 in total

1.  High Systemic Immune Inflammation Index Is Associated With Low Skeletal Muscle Quantity in Resectable Pancreatic Ductal Adenocarcinoma.

Authors:  Mohammad Hosein Aziz; Jelle C van Dongen; Lawlaw Saida; Mustafa Suker; Jeroen L A van Vugt; Yordi van Putten; Kostandinos Sideras; Jesse V Groen; J Sven D Mieog; Claudia J Lucassen; Anneke Droop; Katya Mauff; Shirin Shahbazi Feshtali; Bas Groot Koerkamp; Dana A M Mustafa; Casper J van Eijck
Journal:  Front Oncol       Date:  2022-02-28       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.